Cited by 493Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsBlood Pressure and Hypertension Studies

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study

Vasan, Ramachandran S., Benjamin, Emelia J., Larson, Martin G., Leip, Eric P., Wang, Thomas J., Wilson, Peter W. F., Levy, Daniel·2002·JAMA

DOI 10.1001/jama.288.10.1252

Open this paper in CoChat — free account

Abstract

CONTEXT: Several reports have suggested the usefulness of plasma brain natriuretic peptide (BNP) as a screening test for left ventricular hypertrophy (LVH) and systolic dysfunction (LVSD). Prior studies were limited by small sample sizes and selection bias and none compared the diagnostic performance of these peptides in men and women. OBJECTIVES: To examine the usefulness of natriuretic peptides for screening for elevated LV mass and LVSD in the community. DESIGN, SETTING, AND PARTICIPANTS: Community-based prospective cohort study of 3177 participants (1707 women) from the Framingham Study who attended a routine examination in 1995-1998. MAIN OUTCOME MEASURES: Receiver operating characteristic (ROC) curves, test sensitivity, specificity, positive and negative predictive values, and likelihood ratios for identifying elevated LV mass (sex-specific 90th percentile or higher of LV mass/[height](2)), LVSD (ejection fraction < or = 50% and/or fractional shortening <29%), and moderate to severe LVSD (ejection fraction < or = 40% and/or fractional shortening <22%) at different discrimination limits of plasma BNP and N-terminal proatrial natriuretic peptide (NT-ANP), with echocardiography as the criterion standard. RESULTS: The areas under the ROC curves for elevated LV mass or LVSD were at or below 0.75 for both peptides, were higher for men compared with women, and were similar for BNP and NT-ANP. The diagnostic performance of natriuretic peptides for LVSD improved in women but not…

Integrity signals

Registry

Crossref · 10.1001/jama.288.10.1252

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Applied logistic regression
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
Sahn, D. J., DeMaria, A. N., KISSLO, J. A., & Weyman, A. E. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
A method of comparing the areas under receiver operating characteristic curves derived from the same cases
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Self-citation
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Users' Guides to the Medical Literature
Jaeschke, R. (1994) · JAMA · doi:10.1001/jama.271.9.703 · Cited by 2,688
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639

Show all 42 references

Sorted by citations

2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,137
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,739
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
Redfield, M. M., Jacobsen, S. J., Burnett, J. C. J., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 2,989
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,234
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D. A., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,521
Self-citation
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,398
B-type natriuretic peptide in cardiovascular disease
de Lemos, J. A., McGuire, D. K., & Drazner, M. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13976-1 · Cited by 1,068
Artificial intelligence-enhanced electrocardiography in cardiovascular disease management
Siontis, K. C., Noseworthy, P. A., Attia, Z. I., & Friedman, P. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00503-2 · Cited by 914
State of the art: using natriuretic peptide levels in clinical practice
Maisel, A., Mueller, C., Adams, K., Anker, S. D., Aspromonte, N., Cleland, J. G. F., Cohen-Solal, A., Dahlstrom, U., DeMaria, A., Di Somma, S., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.07.014 · Cited by 839
Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
Mueller, C. E., McDonald, K., de Boer, R. A., Maisel, A. S., Cleland, J. G. F., Kozhuharov, N., Coats, A. J. S., Metra, M., Mebazaa, A., Ruschitzka, F. T., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1494 · Cited by 850
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Ho, J. E., Liu, C., Lyass, A., Courchesne, P. L., Pencina, M. J., Vasan, R. S., Larson, M. G., & Levy, D. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.053 · Cited by 611
Self-citation
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Armenian, S. H., Hudson, M. M., Mulder, R. L., Chen, M. H., Constine, L. S., Dwyer, M., Nathan, P. C., Tissing, W. J. E., Shankar, S., Sieswerda, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70409-7 · Cited by 570
N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
Kistorp, C. (2005) · JAMA · doi:10.1001/jama.293.13.1609 · Cited by 535
Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
Mant, J., Doust, J., Roalfe, A., Barton, P., Cowie, M., Glasziou, P., Mant, D., McManus, R., Holder, R., Deeks, J., et al. (2009) · Health Technology Assessment · doi:10.3310/hta13320 · Cited by 498
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167587 · Cited by 469
Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis
Charpentier, J., Luyt, C. E., Fulla, Y., Vinsonneau, C., Cariou, A., Grabar, S., Dhainaut, J.-F., Mira, J. P., & Chiche, J. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000114827.93410.d8 · Cited by 429
BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases
Silver, M. A., Maisel, A. S., Yancy, C. W., McCullough, P. A., Burnett, J. C. J., Francis, G. S., Mehra, M. R., Peacock, W. F., Fonarow, G. C., Gibler, W. B., et al. (2004) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2004.03271.x · Cited by 361
Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A Review
Clerico, A., & Emdin, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.024760 · Cited by 332
A Systematic Review of the Diagnostic Accuracy of Natriuretic Peptides for Heart Failure
Doust, J. A., Glasziou, P., Pietrzak, E. R., & Dobson, A. J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.18.1978 · Cited by 323
Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the Community
Lam, C. S. P., Lyass, A., Kraigher‐Krainer, E., Massaro, J. M., Lee, D. S., Ho, J. E., Levy, D. A., Redfield, M. M., Pieske, B. M., Benjamin, E. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.979203 · Cited by 317
Self-citation
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
Tang, W. H. W., Francis, G. S., Morrow, D. A., Newby, L. K., Cannon, C. P., Jesse, R. L., Storrow, A. B., Christenson, R. H., Christenson, R. H., Apple, F. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.185267 · Cited by 311
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.023 · Cited by 319
70-year legacy of the Framingham Heart Study
Andersson, C., Johnson, A. D., Benjamin, E. J., Levy, D., & Vasan, R. S. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0202-5 · Cited by 305
Self-citation
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.020 · Cited by 302
Normal values of B type natriuretic peptide in infants, children, and adolescents
Koch, A., & Singer, H. (2003) · Heart · doi:10.1136/heart.89.8.875 · Cited by 273
Plasma Brain Natriuretic Peptide to Detect Preclinical Ventricular Systolic or Diastolic Dysfunction
Redfield, M. M., Rodeheffer, R. J., Jacobsen, S. J., Mahoney, D. W., Bailey, K. R., & Burnett, J. C. J. (2004) · Circulation · doi:10.1161/01.cir.0000130845.38133.8f · Cited by 260
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications
Clerico, A., Recchia, F. A., Passino, C., & Emdin, M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00684.2005 · Cited by 257
Cardiac Hormones as Diagnostic Tools in Heart Failure
Ruskoaho, H. J. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0006 · Cited by 251
Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study
Rutten, F. H., Moons, K. G. M., Cramer, M. J., Grobbee, D. E., Zuithoff, N. P. A., Lammers, A.-W. J., & Hoes, A. W. (2005) · BMJ · doi:10.1136/bmj.38664.661181.55 · Cited by 239
The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening
Wang, T. J., Levy, D., Benjamin, E. J., & Vasan, R. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00012 · Cited by 229
Self-citation
B-Type Natriuretic Peptide and Ischemia in Patients With Stable Coronary Disease
Bibbins-Domingo, K. B., Ansari, M. N., Schiller, N. B., Massie, B. M., & Whooley, M. A. (2003) · Circulation · doi:10.1161/01.cir.0000103681.04726.9c · Cited by 226
Genetic Variants Associated With Cardiac Structure and Function
Vasan, R. S., Glazer, N. L., Felix, J. F., Lieb, W., Wild, P. S., Felix, S. B., Watzinger, N., Larson, M. G., Smith, N. L., Dehghan, A., et al. (2009) · JAMA · doi:10.1001/jama.2009.978-a · Cited by 218
Self-citation
Risk Factors for Heart Failure
Lawson, C. A., Zaccardi, F., Squire, I. B., Okhai, H., Davies, M. J., Huang, W., Mamas, M. A., Lam, C. S. P., Khunti, K., & Kadam, U. T. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006472 · Cited by 212
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides
Nishikimi, T., Kuwahara, K., & Nakao, K. (2011) · Journal of Cardiology · doi:10.1016/j.jjcc.2011.01.002 · Cited by 199
Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure
Fu, S., Ping, P., Wang, F., & Luo, L. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-017-0093-0 · Cited by 208
10-Year Risk Equations for Incident Heart Failure in the General Population
Khan, S. S., Ning, H., Shah, S. J., Yancy, C. W., Carnethon, M. R., Berry, J. D., Mentz, R. J., O'Brien, E. C., Correa, A., Suthahar, N., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.057 · Cited by 203
B-type natriuretic peptides: a diagnostic breakthrough for clinicians.
McCullough, P. A., Omland, T., & Maisel, A. S. (2003) · PubMed · Cited by 196
Cardiac remodeling at the population level—risk factors, screening, and outcomes
Gjesdal, O., Bluemke, D. A., & Lima, J. A. C. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.154 · Cited by 194
Association of parental heart failure with risk of heart failure in offspring
Lee, D. S., Pencina, M. J., Benjamin, E. J., Wang, T. J., Levy, D., O'Donnell, C. J., Nam, B.-H., Larson, M. G., D'Agostino, R. B., & Vasan, R. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052948 · Cited by 191
Self-citation
Associations Among Androgens, Estrogens, and Natriuretic Peptides in Young Women
Chang, A. Y., Abdullah, S. M., Jain, T., Stanek, H. G., Das, S. R., McGuire, D. K., Auchus, R. J., & de Lemos, J. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.040 · Cited by 189
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction
Heidenreich, P. A., Gubens, M. A., Fonarow, G. C., Konstam, M. A., Stevenson, L. W., & Shekelle, P. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.043 · Cited by 187
Influence of sex and hormone status on circulating natriuretic peptides
Lam, C. S. P., Cheng, S., Choong, K., Larson, M. G., Murabito, J. M., Newton-Cheh, C., Bhasin, S., McCabe, E. L., Miller, K. K., Redfield, M. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.042 · Cited by 181
Self-citation
Comparison of B-Type Natriuretic Peptides for Assessment of Cardiac Function and Prognosis in Stable Ischemic Heart Disease
Richards, M., Nicholls, M. G., Espiner, E. A., Lainchbury, J. G., Troughton, R. W., Elliott, J. M., FRAMPTON, C. M. A., Crozier, I., Yandle, T. G., Doughty, R. N., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.085 · Cited by 170
Premature Atrial Contractions in the General Population
Conen, D., Adam, M., Roche, F., Barthélemy, J., Dietrich, D. F., Imboden, M., Künzli, N., von Eckardstein, A., Regenass, S., Hornemann, T., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.112300 · Cited by 174
N-Terminal Pro Brain Natriuretic Peptide Is Inversely Related to Metabolic Cardiovascular Risk Factors and the Metabolic Syndrome
Olsen, M. H., Hansen, T. W., Christensen, M. K., Gustafsson, F., Rasmussen, S. L., Wachtell, K., Borch‐Johnsen, K., Ibsen, H., Jørgensen, T., & Hildebrandt, P. R. (2005) · Hypertension · doi:10.1161/01.hyp.0000179575.13739.72 · Cited by 165
Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women
Resnik, J. L., Hong, C., Resnik, R. R., Kazanegra, R., Beede, J., Bhalla, V., & Maisel, A. S. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.006 · Cited by 161
Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis
von Bibra, H., & Sutton, M. S. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1682-3 · Cited by 158
Heart failure
Krum, H., & Abraham, W. T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60236-1 · Cited by 166
What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?
Galasko, G. I. W., Lahiri, A., Barnes, S. C., Collinson, P. O., & Senior, R. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi410 · Cited by 157
N-Terminal Pro-Brain Natriuretic Peptide
Wang, A. Y.-M., Lam, C. W.-K., Yu, C., Wang, M., Chan, I. H.-S., Zhang, Y., Lui, S., & Sanderson, J. E. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121299 · Cited by 156
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers
Arnold, J. M. O., Howlett, J. G., Dorian, P., Ducharme, A., Giannetti, N., Haddad, H. A., Heckman, G. A., Ignaszewski, A. P., Isaac, D., Jong, P., et al. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70211-8 · Cited by 150
The natriuretic peptides in cardiovascular medicine
Munagala, V. K., BURNETTJR, J., & Redfield, M. M. (2004) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2004.07.002 · Cited by 151
Detection of Left Ventricular Systolic Dysfunction From Electrocardiographic Images
Sangha, V., Nargesi, A. A., Dhingra, L. S., Khunte, A., Mortazavi, B. J., Ribeiro, A. H., Banina, E., Adeola, O., Garg, N., Brandt, C. A., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.062646 · Cited by 150
Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome
Schlueter, N., de Sterke, A., Willmes, D. M., Spranger, J., Jordan, J., & Birkenfeld, A. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.04.007 · Cited by 149
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review
Clerico, A., Fontana, M., Zyw, L., Passino, C., & Emdin, M. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.075713 · Cited by 148
Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock*
Tung, R. H., García, C. M. C., Morss, A. M., Pino, R. M., Fifer, M. A., Thompson, B., Lewandrowski, K. B., Lee-Lewandrowski, E., & Januzzi, J. L. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000133694.28370.7f · Cited by 144
Screening for heart disease in diabetic subjects
Fang, Z. Y., Schull-Meade, R., Leano, R., Mottram, P. M., Prins, J. B., & Marwick, T. H. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.06.021 · Cited by 144
Artificial intelligence-enhanced electrocardiography for accurate diagnosis and management of cardiovascular diseases
Muzammil, M. A., Javid, S., Afridi, A. K., Siddineni, R., Shahabi, M., Haseeb, M. A., Fariha, F., Kumar, S., Zaveri, S., & Nashwan, A. J. (2024) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2024.01.006 · Cited by 155
Left Ventricular Hypertrophy Patterns and Incidence of Heart Failure With Preserved Versus Reduced Ejection Fraction
Velagaleti, R. S., Gona, P. N., Pencina, M. J., Aragam, J. R., Wang, T. J., Levy, D. A., D’Agostino, R. B., Lee, D. S., Kannel, W. B., Benjamin, E. J., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.09.028 · Cited by 144
Self-citation
Reference Ranges for Natriuretic Peptides for Diagnostic Use are Dependent on Age, Gender and Heart Rate
Loke, I. W., Squire, I. B., Davies, J. E., & Ng, L. L. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00108-9 · Cited by 135
Risk factors for heart failure
Kenchaiah, S., Narula, J., & Vasan, R. S. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.016 · Cited by 136
Self-citation
Genome-wide association with select biomarker traits in the Framingham Heart Study
Benjamin, E. J., Dupuis, J., Larson, M. G., Lunetta, K. L., Booth, S. L., Govindaraju, D. R., Kathiresan, S., Keaney, J. F., Keyes, M. J., Lin, J., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s11 · Cited by 124
Self-citation
Meta‐analysis of B type natriuretic peptide and N‐terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction
Ewald, B. D., Ewald, D., Thakkinstian, A., & Attia, J. (2007) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2007.01454.x · Cited by 123
Natriuretic peptides in the diagnosis and management of heart failure
Felker, G. M. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060236 · Cited by 122
Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions
Burke, M. A., & Cotts, W. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9002-9 · Cited by 121
Electrocardiographic QRS Duration and the Risk of Congestive Heart Failure
Dhingra, R., Pencina, M. J., Wang, T. J., Nam, B., Benjamin, E. J., Levy, D. A., Larson, M. G., Kannel, W. B., D’Agostino, R. B., & Vasan, R. S. (2006) · Hypertension · doi:10.1161/01.hyp.0000217141.20163.23 · Cited by 124
Self-citation
Pre-Clinical Diabetic Cardiomyopathy: Prevalence, Screening, and Outcome
Kiencke, S., Handschin, R., von Dahlen, R., Muser, J., Rocca, H. B., Schumann, J., Felix, B., Berneis, K. K., & Rickenbacher, P. R. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq110 · Cited by 119
Galectin 3 and incident atrial fibrillation in the community
Ho, J. E., Yin, X., Levy, D. A., Vasan, R. S., Magnani, J. W., Ellinor, P. T., McManus, D. D., Lubitz, S. A., Larson, M. G., & Benjamin, E. J. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.02.009 · Cited by 119
Self-citation
Early detection of myocardial dysfunction and heart failure
de Couto, G., Ouzounian, M., & Liu, P. P. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.51 · Cited by 119
Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes
Ingelsson, E., SULLIVAN, L. M., Murabito, J. M., Fox, C. S., Benjamin, E. J., Polak, J. F., Meigs, J. B., Keyes, M. J., O’Donnell, C. J., Wang, T. J., et al. (2007) · Diabetes · doi:10.2337/db07-0078 · Cited by 113
Self-citation
Prognosis of Individuals With Asymptomatic Left Ventricular Systolic Dysfunction in the Multi-Ethnic Study of Atherosclerosis (MESA)
Yeboah, J., Rodríguez, C. J., Stacey, B. R., Lima, J. A. C., Liu, S., Carr, J. J., Hundley, W. G., & Herrington, D. M. (2012) · Circulation · doi:10.1161/circulationaha.112.112201 · Cited by 114
Diagnosis of heart failure in primary care
Fonseca, C. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-9481-0 · Cited by 113
Natriuretic peptides: markers or modulators of cardiac hypertrophy?
GARDNER, D. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00113-9 · Cited by 111
Relations of Serum Phosphorus Levels to Echocardiographic Left Ventricular Mass and Incidence of Heart Failure in the Community
Dhingra, R., Gona, P., Benjamin, E. J., Wang, T. J., Aragam, J., D'Agostino, R. B., Kannel, W. B., & Vasan, R. S. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq106 · Cited by 108
Self-citation
Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study
de Lemos, J. A., McGuire, D. K., Khera, A., Das, S. R., Murphy, S. A., Omland, T., & Drazner, M. H. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.017 · Cited by 103
Measuring plasma B-type natriuretic peptide in heart failure
Rodeheffer, R. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.082 · Cited by 103
Gout and the risk for incident heart failure and systolic dysfunction
Krishnan, E. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000282 · Cited by 101
Manganese exposure among smelting workers: blood manganese–iron ratio as a novel tool for manganese exposure assessment
Cowan, D. M., Fan, Q., Zou, Y., Shi, X., Chen, J., Aschner, M., Rosenthal, F. S., & Zheng, W. (2009) · Biomarkers · doi:10.1080/13547500902730672 · Cited by 101
Brain Natriuretic Peptide in the Management of Heart Failure
de Denus, S., Pharand, C., & Williamson, D. R. (2004) · CHEST Journal · doi:10.1378/chest.125.2.652 · Cited by 98
Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations
Oyama, M. A., Sisson, D. D., & Solter, P. F. (2007) · American Journal of Veterinary Research · doi:10.2460/ajvr.68.1.42 · Cited by 97
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
Tang, W. H. W., Francis, G. S., Morrow, D. A., Newby, L. K., Cannon, C. P., Jesse, R. L., Storrow, A. B., Christenson, R. H., Christenson, R. H., Apple, F. S., et al. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.07.002 · Cited by 97
Population Risk Prediction Models for Incident Heart Failure
Echouffo-Tcheugui, J. B., Greene, S. J., Papadimitriou, L., Zannad, F. M., Yancy, C. W., Gheorghiade, M., & Butler, J. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001896 · Cited by 97
Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure
Ng, L. L., Pathik, B., Loke, I. W., Squire, I. B., & Davies, J. E. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.09.020 · Cited by 95
Detection of left ventricular systolic dysfunction from single-lead electrocardiography adapted for portable and wearable devices
Khunte, A., Sangha, V., Oikonomou, E. K., Dhingra, L. S., Aminorroaya, A., Mortazavi, B. J., Coppi, A., Brandt, C. A., Krumholz, H. M., & Khera, R. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00869-w · Cited by 95
Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction
Katz, D. H., Deo, R. C., Aguilar, F. G., Selvaraj, S., Martinez, E. E., Beussink‐Nelson, L., Kim, K. A., Peng, J., Irvin, M. R., Tiwari, H. K., et al. (2017) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-017-9739-z · Cited by 95
B-Type Natriuretic Peptide as a Biomarker Beyond Heart Failure: Speculations and Opportunities
McKie, P. M., & Burnett, J. C. J. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.8.1029 · Cited by 95
Natriuretic Peptides as Markers of Mild Forms of Left Ventricular Dysfunction: Effects of Assays on Diagnostic Performance of Markers
Hammerer‐Lercher, A., Ludwig, W., Falkensammer, G., Müller, S., Neubauer, E., Puschendorf, B., Pachinger, O. M., & Mair, J. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.028316 · Cited by 94
Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction
Goetze, J. P., Møgelvang, R., Maage, L., Scharling, H., Schnohr, P., Søgaard, P., Rehfeld, J. F., & Jensen, J. S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl406 · Cited by 94
Framingham Heart Study
Andersson, C., Nayor, M. G., Tsao, C. W., Levy, D. A., & Vasan, R. S. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.059 · Cited by 107
Self-citation
Comparison of B-Type Natriuretic Peptide Assays for Identifying Heart Failure in Stable Elderly Patients with a Clinical Diagnosis of Chronic Obstructive Pulmonary Disease
Rutten, F. H., Cramer, M. J., Zuithoff, N. P. A., Lammers, J. J., Verweij, W. M., Grobbee, D. E., & Hoes, A. W. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.01.010 · Cited by 92
The heart as an endocrine organ
Ogawa, T., & de Bold, A. J. (2014) · Endocrine Connections · doi:10.1530/ec-14-0012 · Cited by 91
Reduced Myocardial Velocities of Left Ventricular Long-Axis Contraction Identify Both Systolic and Diastolic Heart Failure—A Comparison with Brain Natriuretic Peptide
Vinereanu, D., Lim, P. O., Frenneaux, M. P., & Fraser, A. G. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.07.014 · Cited by 91
B-Type Natriuretic Peptides and Echocardiographic Measures of Cardiac Structure and Function
Troughton, R. W., & Richards, M. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.12.006 · Cited by 87
Improving the Primary Prevention of Cardiovascular Events by Using Biomarkers to Identify Individuals With Silent Heart Disease
Nadir, M. A., Rekhraj, S., Wei, L., Lim, T. K., Davidson, J., MacDonald, T. M., Lang, C. C., Dow, E., & Struthers, A. D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.049 · Cited by 85
Comparison of Brain Natriuretic Peptide (BNP) and Amino-Terminal ProBNP for Early Diagnosis of Heart Failure
Emdin, M., Passino, C., Prontera, C., Fontana, M., Poletti, R., Gabutti, A., Mammini, C., Giannoni, A., Zyw, L., Zucchelli, G., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.080234 · Cited by 84
Prevalence of Pulmonary Hypertension in the General Population: The Rotterdam Study
Moreira, E. M., Gall, H. J., Leening, M. J. G., Lahousse, L., Loth, D. W., Krijthe, B. P., Jong, J. C. K., Brusselle, G., Albert Hofman, D., Stricker, B. H. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130072 · Cited by 88
Novel markers for heart failure diagnosis and prognosis
Lee, D. S., & Vasan, R. S. (2005) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000161832.04952.6a · Cited by 81
Self-citation

Authors: Vasan, R. S., Benjamin, E. J., Larson, M. G., Leip, E. P., Wang, T. J., Wilson, P. W. F., & Levy, D.
Affiliations: Framingham Heart Study (US)
Boston University (US)
National Institutes of Health (US)
ORCID: Vasan, Ramachandran S.
Benjamin, Emelia J.
Larson, Martin G.
Wang, Thomas J.
Wilson, Peter W. F.
Levy, Daniel
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2002-09-11
Volume: 288
Issue: 10
Pages: 1252
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.288.10.1252
OpenAlex: W2059920038
Cited by: 493
References: 42
Citations by year: 2026: 3 · 2025: 11 · 2024: 10 · 2023: 14 · 2022: 6 · 2021: 12 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 13 · 2016: 9 · 2015: 16 · 2014: 14 · 2013: 20 · 2012: 29
FWCI: 27.29
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc25195-41-0-1)
National Heart, Lung, and Blood Institute (K24-HL-04334-01A1, N01‐HC25195, R01HL067288, K24HL004334, 1R01HL67288-01)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords: natriuretic peptides, brain natriuretic peptide, N-terminal proatrial natriuretic peptide, left ventricular hypertrophy, left ventricular systolic dysfunction, left ventricular mass, cardiovascular screening, diagnostic performance, sex differences, Framingham Heart Study, echocardiography
MeSH terms: Echocardiography, Female, Humans, Male, Mass Screening, Middle Aged, Atrial Natriuretic Factor, Phenotype, Predictive Value of Tests, Prospective Studies, Protein Precursors, ROC Curve, Sensitivity and Specificity, Systole, Biomarkers, Likelihood Functions, Hypertrophy, Left Ventricular, Ventricular Dysfunction, Left, Natriuretic Peptide, Brain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks